Mira Pharmaceuticals Inc (MIRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 6,347 | 2,833 | 4,603 | 351 |
| Marketable Securities | 4,683 | N/A | N/A | N/A |
| Receivables | N/A | N/A | 12 | N/A |
| Other current assets | 0 | 0 | 0 | 143 |
| TOTAL | $11,058 | $2,888 | $4,858 | $494 |
| Non-Current Assets | ||||
| Other Non-Current Assets | 35 | 35 | 74 | 364 |
| TOTAL | $35 | $35 | $74 | $364 |
| Total Assets | $11,094 | $2,923 | $4,932 | $858 |
| Liabilities | ||||
| Current Liabilities | ||||
| Short Term Debt | N/A | N/A | N/A | 133 |
| Accounts payable and accrued liabilities | 702 | 723 | 539 | 928 |
| Accrued Expenses | N/A | N/A | 15 | 35 |
| TOTAL | $702 | $723 | $558 | $1,370 |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 84 |
| TOTAL | $N/A | $N/A | $N/A | $84 |
| Total Liabilities | $702 | $723 | $558 | $1,454 |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 42,022 | 16,814 | 14,781 | N/A |
| Common Shares | 4 | 2 | 2 | 7 |
| Retained earnings | -39,580 | -29,138 | -21,285 | -9,303 |
| TOTAL | $10,392 | $2,200 | $4,374 | $-596 |
| Total Liabilities And Equity | $11,094 | $2,923 | $4,932 | $858 |